GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Saniona AB (OSTO:SANION) » Definitions » YoY EBITDA Growth

Saniona AB (OSTO:SANION) YoY EBITDA Growth : 76.08% (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Saniona AB YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Saniona AB's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 76.08%.

Saniona AB's EBITDA per Share for the three months ended in Mar. 2024 was kr-0.07.


Saniona AB YoY EBITDA Growth Historical Data

The historical data trend for Saniona AB's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Saniona AB YoY EBITDA Growth Chart

Saniona AB Annual Data
Trend Jan14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -35.20 46.08 -312.03 50.26 59.79

Saniona AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 82.95 77.32 -154.18 -151.41 76.08

Saniona AB YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Saniona AB's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-1.082--2.691)/ | -2.691 |
=59.79 %

Saniona AB's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(-0.072--0.301)/ | -0.301 |
=76.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Saniona AB YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Saniona AB's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Saniona AB (OSTO:SANION) Business Description

Traded in Other Exchanges
Address
Smedeland 26B, Glostrup, DNK, DK-2600
Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, SAN903, and SAN2219.

Saniona AB (OSTO:SANION) Headlines

No Headlines